Published in Pharmacol Rev on June 01, 1972
Multiple receptors for brain dopamine. Proc Natl Acad Sci U S A (1978) 1.11
Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line. Br J Pharmacol (1996) 0.85
Fifth Gaddum Memorial Lecture, University of Bristol, September 1974, The glycine synaptic receptor in the mammalian central nervous system. Br J Pharmacol (1975) 0.82
Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Br J Pharmacol (1990) 0.75
Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet (1993) 9.88
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med (1995) 4.71
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med (1997) 3.49
A prospective randomised trial of internal fixation versus arthroplasty for displaced fractures of the neck of the femur. Functional outcome for 450 patients at two years. J Bone Joint Surg Br (2002) 3.40
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol (1969) 2.61
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol (1969) 2.26
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect (1993) 2.20
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther (2013) 2.01
Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease. Trends Neurosci (1990) 1.91
Modification of sympathetic function. Pharmacological depletion of catecholamine stores. Pharmacol Rev (1966) 1.56
Natural history of postoperative aneurysm rests. J Neurosurg (1987) 1.55
Magnetic resonance imaging of obliterated arteriovenous malformations up to 23 years after radiosurgery. J Neurosurg (1997) 1.53
Movement patterns of the C-stem femoral component: an RSA study of 33 primary total hip arthroplasties followed for two years. J Bone Joint Surg Br (2005) 1.53
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med (1993) 1.50
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand (1967) 1.49
Continuous distal migration and internal rotation of the C-stem prosthesis without any adverse clinical effects: an RSA study of 33 primary total hip arthroplasties followed for up to ten years. Bone Joint J (2014) 1.45
Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry (2000) 1.43
Insect immunity. The primary structure of the antibacterial protein attacin F and its relation to two native attacins from Hyalophora cecropia. EMBO J (1984) 1.35
Oral L-dopa treatment of parkinsonism. Acta Med Scand (1970) 1.35
Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. J Pharm Pharmacol (1969) 1.34
Ammonia synthesis from first-principles calculations. Science (2005) 1.33
Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.31
Long-term follow-up of replacement compared with internal fixation for displaced femoral neck fractures: results at ten years in a randomised study of 450 patients. J Bone Joint Surg Br (2010) 1.30
Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines. J Pharm Pharmacol (1966) 1.29
Blood pressure course in patients with acute stroke and matched controls. Stroke (1986) 1.28
Perspectives on the discovery of central monoaminergic neurotransmission. Annu Rev Neurosci (1987) 1.27
The effect of imipramine on central 5-hydroxytryptamine neurons. J Pharm Pharmacol (1968) 1.21
Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull (1990) 1.20
The antibacterial effect of attacins from the silk moth Hyalophora cecropia is directed against the outer membrane of Escherichia coli. EMBO J (1984) 1.19
Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.19
Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm (1976) 1.18
Bone mass in primary coxarthrosis. Acta Orthop Scand (1979) 1.18
Exposure to toluene: uptake, distribution and elimination in man. Scand J Work Environ Health (1982) 1.17
Antibiotic prophylaxis in recurrent erysipelas. Infection (1994) 1.17
Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol (1995) 1.15
Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryptamine in the rat spinal cord. Naunyn Schmiedebergs Arch Pharmacol (1973) 1.13
Does tranexamic acid reduce blood loss in knee arthroplasty? Am J Knee Surg (1995) 1.12
Clinical aspects of osseointegration in joint replacement. A histological study of titanium implants. J Bone Joint Surg Br (1988) 1.12
Adrenergic mechanisms. Annu Rev Pharmacol (1969) 1.11
Unexpectedly large mass loss during the thermal pulse cycle of the red giant star R Sculptoris. Nature (2012) 1.11
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm (1989) 1.10
Schizophrenia: from dopamine to glutamate and back. Curr Med Chem (2004) 1.09
Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease. Gut (2006) 1.09
Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest (2008) 1.09
The effect of taurine on motor behaviour, body temperature and monoamine metabolism in rat brain. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.08
Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women. J Clin Immunol (2001) 1.08
Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry (1978) 1.07
Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl (1980) 1.07
Prevalence of symptoms and signs indicative of temporomandibular disorders in children and adolescents. A cross-sectional epidemiological investigation covering two decades. Eur Arch Paediatr Dent (2009) 1.06
Cerebral blood flow and substrate utilization in insulin-treated diabetic subjects. Am J Physiol (1990) 1.06
A 20-year longitudinal study of subjective symptoms of temporomandibular disorders from childhood to adulthood. Acta Odontol Scand (2001) 1.06
Mannose-resistant haemagglutination by Campylobacter pylori. Scand J Infect Dis (1988) 1.05
8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem (1981) 1.04
Exposure to toluene: concentration in subcutaneous adipose tissue. Scand J Work Environ Health (1982) 1.04
Gloverin, an antibacterial protein from the immune hemolymph of Hyalophora pupae. Eur J Biochem (1997) 1.04
The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity (2011) 1.04
The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain. J Neurochem (1973) 1.03
Does dopamine play a role in schizophrenia? Psychol Med (1977) 1.02
Vibration white finger: a follow up study. Br J Ind Med (1987) 1.02
Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J Pharm Pharmacol (1972) 1.02
Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol (2000) 1.02
The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.02
Aseptic loosening of hip prostheses. A histologic and enzyme histochemical study. Clin Orthop Relat Res (1983) 1.01
Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J Pharm Pharmacol (1970) 1.01
Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol (2008) 1.01
Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biol Psychiatry (1998) 1.01
Effects of antidepressant agents on the synthesis of brain monoamines. J Neural Transm (1978) 1.00
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol (1994) 1.00
An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues. Acta Physiol Scand (1967) 1.00
Social function after cervical hip fracture. A comparison of hook-pins and total hip replacement in 47 patients. Acta Orthop Scand (1996) 1.00
[The "free" lipids of Brucella abortus Bang. Concerning the neutral lipids]. Eur J Biochem (1969) 1.00
Does dopamine have a role in schizophrenia? Biol Psychiatry (1978) 1.00
Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav (1981) 0.99
Very high blood pressure in acute stroke. J Intern Med (1990) 0.99
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther (2006) 0.99
C-peptide in the classification of diabetes in children and adolescents. Pediatr Diabetes (2011) 0.98
In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain. J Neural Transm (1986) 0.98
The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J Neural Transm Park Dis Dement Sect (1989) 0.98
Detection of 5-S-cysteinyldopamine in human brain. J Neural Transm (1985) 0.98
A longitudinal study on malocclusion in relation to signs and symptoms of cranio-mandibular disorders in children and adolescents. Eur J Orthod (1990) 0.98
Biochemical and pharmacological aspects of Parkinsonism. Acta Neurol Scand Suppl (1972) 0.98
Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis. Curr Drug Targets CNS Neurol Disord (2002) 0.97
Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol (2005) 0.97
Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro. J Pharm Pharmacol (1965) 0.97